nathan davis executive director medreleaf australia drive change

Our GPs are continually frustrated by the current driving laws that prevent them from offering a safe and effective alternative to commonly prescribed and sedating compounds such as opioids and benzodiazepines. We need to have confidence that GPs are more than capable of managing a patients therapy, whether the patient wishes to drive to work or otherwise.

Nathan Davis

Executive Director, MedReleaf Australia
Recent posts
frequently asked questions

Answering Cannabis Law FAQ

With cannabis available via a prescription in Australia since 2016, both doctors and patients are increasingly more likely to consider it as part of a healthcare practice. Medicinal cannabis is already widely prescribed for conditions including PTSD, chronic pain, anxiety, and insomnia. Although the health industry generally agrees with its medicinal merits, the driving laws […]

Read more
doctor types at the computer

Dr Teresa Towpik: “Ignorance Isn’t Bliss, Knowledge Is.”

This article is written by Drive Change ambassador Dr. Teresa Towpik. Below, she shares her experience with the drug driving laws from the standpoint of a medicinal cannabis doctor and patient. January 2016–what a month it was for me.  I didn’t realise it then, but this would mark the beginning of a new chapter in […]

Read more